Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06822504 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevalence of Sarcopenic Obesity in COPD

Study acronym: OS-BPCO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
IRCCS San Raffaele Roma
30 trials monitored
See all monitored trials
Obesity
3,874 trials monitored
See 152 trials at risk
COPD
1,119 trials monitored
See 34 trials at risk
The goal of this observational study is to the purpose is to apply of ESPEN/EASO criteria for the diagnosis of sarcopenic obesity and calculation of OS prevalence in a sample of COPD patients. In addition, this study want to evaluate the impact of sarcopenic obesity on the respiratory function of COPD patients and the degree of severity of respiratory disease, assessed by spirometric examination; diaphragm thickness and excursion, by ultrasonographic study; performance, assessed by six-minute walk test (6-MWT); quality of life and degree of dyspnea (mMRC, Barthel dyspnea, S. George Respiratory Questionnaire); compliance and outcomes at the end of the respiratory rehabilitation course. Comparison with normal-weight patients with and without sarcopenia will help to better understand the clinical impact of sarcopenic obesity in this category of patients.
Trial Details
NCT Number NCT06822504
Lead Sponsor IRCCS San Raffaele Roma
Conditions
(from sponsor)		 Sarcopenic Obesity, COPD
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 236 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov